BERGENBIO ASA

5008 BERGEN

Finances

Share Ownership

Return on Equity

−341,39 %

Current Ratio

2,14

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	389 000	774 000	601 000	8 900 000
Net Income	−302 121 000	−309 363 000	−257 029 000	−199 280 000
Total Assets	166 706 000	450 235 000	738 201 000	270 378 000
Total Equity	88 498 000	384 427 000	670 229 000	219 754 000

Income (NOK)	2022	2021	2020	2019
Revenue	389 000	774 000	601 000	8 900 000
Expenditure	306 023 000	315 237 000	261 692 000	213 275 000
Operating Profit	−305 634 000	−314 463 000	−261 091 000	−204 375 000
Financial Income	15 027 000	15 994 000	19 499 000	11 529 000
Financial Costs	11 514 000	10 894 000	15 437 000	6 434 000
Financial Balance	3 513 000	5 100 000	4 062 000	5 095 000
Earnings Before Tax	−302 121 000	−309 363 000	−257 029 000	−199 280 000
Tax	0	0	0	0
Net Income	−302 121 000	−309 363 000	−257 029 000	−199 280 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	43 000	1 191 000	2 332 000	974 000
Total Current Assets	166 663 000	449 044 000	735 869 000	269 404 000
Total Assets	166 706 000	450 235 000	738 201 000	270 378 000
Total Retained Equity	0	0	0	0
Total Equity	88 498 000	384 427 000	670 229 000	219 754 000
Total Long-Term Debt	275 000	942 000	1 367 000	0
Total Current Debt	77 933 000	64 867 000	66 604 000	50 623 000
Total Equity and Debt	166 706 000	450 236 000	738 200 000	270 377 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	389 000	774 000	601 000	8 900 000
Other Income	0	0	0	0
Revenue	389 000	774 000	601 000	8 900 000
Cost of Goods Sold	0	0	0	0
Salary Costs	68 689 000	74 045 000	60 178 000	35 717 000
Depreciation	883 000	1 312 000	726 000	785 000
Impairment	0	0	0	0
Expenditure	306 023 000	315 237 000	261 692 000	213 275 000
Operating Profit	−305 634 000	−314 463 000	−261 091 000	−204 375 000
Financial Income	15 027 000	15 994 000	19 499 000	11 529 000
Financial Costs	11 514 000	10 894 000	15 437 000	6 434 000
Financial Balance	3 513 000	5 100 000	4 062 000	5 095 000
Dividends	0	0	0	0
Net Income	−302 121 000	−309 363 000	−257 029 000	−199 280 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	43 000	1 191 000	2 332 000	974 000
Total Tangible Assets	43 000	1 191 000	2 332 000	974 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	43 000	1 191 000	2 332 000	974 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	150 803 000	436 646 000	721 641 000	253 586 000
Total Current Assets	166 663 000	449 044 000	735 869 000	269 404 000
Total Assets	166 706 000	450 235 000	738 201 000	270 378 000
Total Equity	88 498 000	384 427 000	670 229 000	219 754 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	275 000	942 000	1 367 000	0
Creditors	29 634 000	26 726 000	22 550 000	26 746 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	48 299 000	38 141 000	44 054 000	23 877 000
Total Current Debt	77 933 000	64 867 000	66 604 000	50 623 000
Total Equity and Debt	166 706 000	450 236 000	738 200 000	270 377 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−341,39 %	−80,47 %	−38,35 %	−90,68 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−78 569,15 %	−40 628,29 %	−43 442,76 %	−2 296,35 %
Current Ratio	2,14	6,92	11,05	5,32
Quick Ratio	2,14	6,92	11,05	5,32
Equity Ratio	0,53	0,85	0,91	0,81
Gross Profit Margin	100 %	100 %	100 %	100 %